# Laser vs Clobetasol for Lichen Sclerosus

> **NCT05010421** · PHASE3 · COMPLETED · sponsor: **Ruhr University of Bochum** · enrollment: 246 (actual)

## Conditions studied

- Lichen Sclerosus

## Interventions

- **DRUG:** Clobetasol 0.05% Emollient Top Cream
- **DEVICE:** Non-ablative CO2 Laser

## Key facts

- **NCT ID:** NCT05010421
- **Lead sponsor:** Ruhr University of Bochum
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-02
- **Primary completion:** 2025-07-10
- **Final completion:** 2025-10-17
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05010421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05010421, "Laser vs Clobetasol for Lichen Sclerosus". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05010421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*